% alzhub.org library filter
% Source: https://alzhub.org/research?institution=I867280407&score_min=67
% 15 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{kunkle2019-30820047,
  author  = {Kunkle, B. W. and Grenier-Boley, B. and Sims, R. and Bis, J. C. and Damotte, V. and Naj, A. C. and Boland, A. and Vronskaya, M. and others},
  title   = {{Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing}},
  journal = {Nature genetics},
  year    = {2019},
  doi     = {10.1038/s41588-019-0358-2},
  pmid    = {30820047},
  url     = {https://doi.org/10.1038/s41588-019-0358-2}
}

@article{he2025-40258956,
  author  = {He, J. and Zhao, C. and Zhong, S. and Ouyang, N. and Sun, G. and Qiao, L. and others},
  title   = {{Blood pressure reduction and all-cause dementia in people with uncontrolled hypertension: an open-label, blinded-endpoint, cluster-randomized trial}},
  journal = {Nature Medicine},
  year    = {2025},
  doi     = {10.1038/s41591-025-03616-8},
  pmid    = {40258956},
  url     = {https://doi.org/10.1038/s41591-025-03616-8}
}

@article{ossenkoppele2015-25988463,
  author  = {Ossenkoppele, R. and Jansen, W. J. and Rabinovici, G. D. and Knol, D. L. and van der Flier, W. M. and van Berckel, B. N. and Scheltens, P. and Visser, P. J. and others},
  title   = {{Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis}},
  journal = {JAMA},
  year    = {2015},
  doi     = {10.1001/jama.2015.4669},
  pmid    = {25988463},
  url     = {https://doi.org/10.1001/jama.2015.4669}
}

@article{naj2011-21460841,
  author  = {Naj, A. C. and Jun, G. and Beecham, G. W. and Wang, L. S. and Vardarajan, B. N. and Buros, J. and Gallins, P. J. and Buxbaum, J. D. and others},
  title   = {{Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease}},
  journal = {Nature genetics},
  year    = {2011},
  doi     = {10.1038/ng.801},
  pmid    = {21460841},
  url     = {https://doi.org/10.1038/ng.801}
}

@article{rajabli2025-40676597,
  author  = {Rajabli, F. and Benchek, P. and Tosto, G. and Kushch, N. and Sha, J. and Bazemore, K. and Zhu, C. and Lee, W. P. and others},
  title   = {{Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer's disease}},
  journal = {Genome biology},
  year    = {2025},
  doi     = {10.1186/s13059-025-03564-z},
  pmid    = {40676597},
  url     = {https://doi.org/10.1186/s13059-025-03564-z}
}

@article{pottier2025-40280976,
  author  = {Pottier, Cyril P. and Küçükali, Fahri and Baker, Matt C. and Batzler, Anthony and Jenkins, Gregory D. and van Blitterswijk, Marka and Vicente, Cristina T. and De Coster, Wouter and others},
  title   = {{Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencing}},
  journal = {Nature Communications},
  year    = {2025},
  doi     = {10.1038/s41467-025-59216-0},
  pmid    = {40280976},
  url     = {https://doi.org/10.1038/s41467-025-59216-0}
}

@article{rajji2025-40133524,
  author  = {Rajji, T. K. and Baksh, S. N. and Shade, D. M. and Ismail, Z. and Burhan, A. M. and Okhravi, H. R. and Padala, P. R. and Rosenberg, P. B. and Schneider, L. S. and Porsteinsson, A. P. and others},
  title   = {{Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial}},
  journal = {Nature Medicine},
  year    = {2025},
  doi     = {10.1038/s41591-025-03569-y},
  pmid    = {40133524},
  url     = {https://doi.org/10.1038/s41591-025-03569-y}
}

@article{thal1996-8960716,
  author  = {Thal, L. J. and Schwartz, G. and Sano, M. and Weiner, M. and Knopman, D. and Harrell, L. and Bodenheimer, S. and Rossor, M. and others},
  title   = {{A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group}},
  journal = {Neurology},
  year    = {1996},
  doi     = {10.1212/wnl.47.6.1389},
  pmid    = {8960716},
  url     = {https://doi.org/10.1212/wnl.47.6.1389}
}

@article{ayton2015-25988319,
  author  = {Ayton, S. and Faux, N. G. and Bush, A. I. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE}},
  journal = {Nature communications},
  year    = {2015},
  doi     = {10.1038/ncomms7760},
  pmid    = {25988319},
  url     = {https://doi.org/10.1038/ncomms7760}
}

@article{miyagawa2020-31914218,
  author  = {Miyagawa, T. and Brushaber, D. and Syrjanen, J. and Kremers, W. and Fields, J. and Forsberg, L. K. and Heuer, H. W. and Knopman, D. and others},
  title   = {{Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2020},
  doi     = {10.1002/alz.12033},
  pmid    = {31914218},
  url     = {https://doi.org/10.1002/alz.12033}
}

@article{rajji2025-39476073,
  author  = {Rajji, T. K. and Bowie, C. R. and Herrmann, N. and Pollock, B. G. and Lanctôt, K. L. and Kumar, S. and Flint, A. J. and Mah, L. and others},
  title   = {{Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment: A Randomized Clinical Trial}},
  journal = {JAMA psychiatry},
  year    = {2025},
  doi     = {10.1001/jamapsychiatry.2024.3241},
  pmid    = {39476073},
  url     = {https://doi.org/10.1001/jamapsychiatry.2024.3241}
}

@article{zhang2026-41870419,
  author  = {Zhang, R. and Vidoni, E. and Vongpatanasin, W. and Kerwin, D. R. and Cullum, C. M. and Rossetti, H. and Stowe, A. M. and Billinger, S. A. and others},
  title   = {{Effects of Exercise and Intensive Vascular Risk Reduction on Cognitive Function in Older Adults: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2026},
  doi     = {10.1001/jamaneurol.2026.0359},
  pmid    = {41870419},
  url     = {https://doi.org/10.1001/jamaneurol.2026.0359}
}

@article{nelson2019-31039256,
  author  = {Nelson, P. T. and Dickson, D. W. and Trojanowski, J. Q. and Jack, C. R. and Boyle, P. A. and Arfanakis, K. and Rademakers, R. and Alafuzoff, I. and others},
  title   = {{Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report}},
  journal = {Brain : a journal of neurology},
  year    = {2019},
  doi     = {10.1093/brain/awz099},
  pmid    = {31039256},
  url     = {https://doi.org/10.1093/brain/awz099}
}

@article{young2018-30323170,
  author  = {Young, A. L. and Marinescu, R. V. and Oxtoby, N. P. and Bocchetta, M. and Yong, K. and Firth, N. C. and Cash, D. M. and Thomas, D. L. and others},
  title   = {{Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference}},
  journal = {Nature communications},
  year    = {2018},
  doi     = {10.1038/s41467-018-05892-0},
  pmid    = {30323170},
  url     = {https://doi.org/10.1038/s41467-018-05892-0}
}

@article{doraiswamy2012-22786606,
  author  = {Doraiswamy, P. M. and Sperling, R. A. and Coleman, R. E. and Johnson, K. A. and Reiman, E. M. and Davis, M. D. and Grundman, M. and Sabbagh, M. N. and others},
  title   = {{Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study}},
  journal = {Neurology},
  year    = {2012},
  doi     = {10.1212/wnl.0b013e3182661f74},
  pmid    = {22786606},
  url     = {https://doi.org/10.1212/wnl.0b013e3182661f74}
}